A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH.
Inclusion Criteria:
Exclusion Criteria:
Other inclusion and exclusion criteria may apply.
AkeroSynchrony@akerotx.com650-487-6488
Ciudad Autónoma de Buenos Aires, Buenos Aires C1056ABI, Argentina
Ciudad Autónoma de Buenos Aires, Buenos Aires C1199ABB, Argentina
Montpellier Cedex 5, Provence-Alpes-Côte d'Azur Region 34295, France
Hyderabad, Andhra Pradesh 500 082, India
Chandigarh, Punjab 160012, India
Ramat Gan, Central District 5265601, Israel
Incheon, Gyeonggi-do 22332, South Korea